Estándares SEA 2022 para el control global del riesgo cardiovascular

dc.contributor.authorMostaza, Jose Maria
dc.contributor.authorPintó Sala, Xavier
dc.contributor.authorArmario, Pedro
dc.contributor.authorMasana, Luis
dc.contributor.authorReal, José T.
dc.contributor.authorValdivielso, Pedro
dc.contributor.authorArrobas-velilla, Teresa
dc.contributor.authorBaeza-trinidad, Ramón
dc.contributor.authorCalmarza, Pilar
dc.contributor.authorCebollada, Jesús
dc.contributor.authorCivera-andrés, M.
dc.contributor.authorCuende Melero, J.i.
dc.contributor.authorDíaz-díaz, J.l.
dc.contributor.authorFernández Pardo, J.
dc.contributor.authorGuijarro, C.
dc.contributor.authorJericó, Carles
dc.contributor.authorLaclaustra, M.
dc.contributor.authorLahoz, C.
dc.contributor.authorLópez-miranda, J.
dc.contributor.authorMartínez-hervás, S.
dc.contributor.authorMuñiz-grijalvo, O.
dc.contributor.authorPáramo, J.a.
dc.contributor.authorPascual, V.
dc.contributor.authorPedro-botet, J.
dc.contributor.authorPérez-martínez, P.
dc.contributor.authorPlana, N.
dc.contributor.authorPuzo, José
dc.contributor.authorSánchez Chaparro, M.Á.
dc.contributor.authorVila, L.
dc.date.accessioned2022-07-18T17:02:42Z
dc.date.available2022-07-18T17:02:42Z
dc.date.issued2022-01-01
dc.date.updated2022-07-15T14:01:46Z
dc.description.abstractOne of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation. (c) 2021 The Authors. Published by Elsevier Espana, S.L.U. on behalf of Sociedad Espanola de Arteriosclerosis. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/2445/187818
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.arteri.2021.11.003
dc.relation.ispartofClínica e Investigación en Arteriosclerosis, 2022, vol. 34, issue. 3, p. 130-179
dc.relation.urihttps://doi.org/10.1016/j.arteri.2021.11.003
dc.rightscc by (c) Mostaza, Jose Maria et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.titleEstándares SEA 2022 para el control global del riesgo cardiovascular
dc.typeinfo:eu-repo/semantics/article

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1-s2.0-S0214916821001571-main.pdf
Mida:
3.88 MB
Format:
Adobe Portable Document Format